Cargando…
Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats
BACKGROUND: Knowing the variability of blood coagulation responses to liver damage of different origins can provide a key to curing liver tissues or to mitigating treatment side effects. The aim of the present work was to compare the changes in the main components of hemostasis under experimental dr...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986226/ https://www.ncbi.nlm.nih.gov/pubmed/36574273 http://dx.doi.org/10.1002/ame2.12301 |
_version_ | 1784901116788473856 |
---|---|
author | Korolova, Daria Gryshchenko, Viktoriya Chernyshenko, Tamara Platonov, Oleh Hornytska, Olha Chernyshenko, Volodymyr Klymenko, Pavlo Reshetnik, Yevdokiia Platonova, Tetyana |
author_facet | Korolova, Daria Gryshchenko, Viktoriya Chernyshenko, Tamara Platonov, Oleh Hornytska, Olha Chernyshenko, Volodymyr Klymenko, Pavlo Reshetnik, Yevdokiia Platonova, Tetyana |
author_sort | Korolova, Daria |
collection | PubMed |
description | BACKGROUND: Knowing the variability of blood coagulation responses to liver damage of different origins can provide a key to curing liver tissues or to mitigating treatment side effects. The aim of the present work was to compare the changes in the main components of hemostasis under experimental drug‐induced hepatosis and hepatitis in rats. METHODS: We modeled diclofenac‐induced hepatitis and tetracycline‐induced hepatosis. Hemostasis response was gauged by measuring fibrinogen, factor X, protein C (PC), and prothrombin in plasma. The decarboxylated form of prothrombin was detected by measuring prothrombin index and ecamulin index. Platelet reactivity was studied using aggregometry. RESULTS: Both hepatitis and hepatosis decreased the synthesis of fibrinogen, factor X, and prothrombin. However, protein carboxylation was not disrupted in hepatosis but was much impaired in hepatitis. PC decreased in both models as a consequence of its consumption possibly during inflammatory response. Platelet aggregation rate was lower in hepatosis but higher in hepatitis. CONCLUSIONS: Our findings imply the need for a thorough monitoring of the hemostasis system in liver diseases to avoid possible thrombotic complications. Its state indicates the disorder's rate and character. |
format | Online Article Text |
id | pubmed-9986226 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99862262023-03-07 Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats Korolova, Daria Gryshchenko, Viktoriya Chernyshenko, Tamara Platonov, Oleh Hornytska, Olha Chernyshenko, Volodymyr Klymenko, Pavlo Reshetnik, Yevdokiia Platonova, Tetyana Animal Model Exp Med Regular Articles BACKGROUND: Knowing the variability of blood coagulation responses to liver damage of different origins can provide a key to curing liver tissues or to mitigating treatment side effects. The aim of the present work was to compare the changes in the main components of hemostasis under experimental drug‐induced hepatosis and hepatitis in rats. METHODS: We modeled diclofenac‐induced hepatitis and tetracycline‐induced hepatosis. Hemostasis response was gauged by measuring fibrinogen, factor X, protein C (PC), and prothrombin in plasma. The decarboxylated form of prothrombin was detected by measuring prothrombin index and ecamulin index. Platelet reactivity was studied using aggregometry. RESULTS: Both hepatitis and hepatosis decreased the synthesis of fibrinogen, factor X, and prothrombin. However, protein carboxylation was not disrupted in hepatosis but was much impaired in hepatitis. PC decreased in both models as a consequence of its consumption possibly during inflammatory response. Platelet aggregation rate was lower in hepatosis but higher in hepatitis. CONCLUSIONS: Our findings imply the need for a thorough monitoring of the hemostasis system in liver diseases to avoid possible thrombotic complications. Its state indicates the disorder's rate and character. John Wiley and Sons Inc. 2022-12-27 /pmc/articles/PMC9986226/ /pubmed/36574273 http://dx.doi.org/10.1002/ame2.12301 Text en © 2022 The Authors. Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Regular Articles Korolova, Daria Gryshchenko, Viktoriya Chernyshenko, Tamara Platonov, Oleh Hornytska, Olha Chernyshenko, Volodymyr Klymenko, Pavlo Reshetnik, Yevdokiia Platonova, Tetyana Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats |
title | Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats |
title_full | Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats |
title_fullStr | Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats |
title_full_unstemmed | Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats |
title_short | Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats |
title_sort | blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats |
topic | Regular Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986226/ https://www.ncbi.nlm.nih.gov/pubmed/36574273 http://dx.doi.org/10.1002/ame2.12301 |
work_keys_str_mv | AT korolovadaria bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats AT gryshchenkoviktoriya bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats AT chernyshenkotamara bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats AT platonovoleh bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats AT hornytskaolha bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats AT chernyshenkovolodymyr bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats AT klymenkopavlo bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats AT reshetnikyevdokiia bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats AT platonovatetyana bloodcoagulationfactorsandplateletresponsetodruginducedhepatitisandhepatosisinrats |